Dihydromyricetin protects neurons in an MPTP-induced model of Parkinson’s disease by suppressing glycogen synthase kinase-3 beta activity - Ren, Z X; Zhao, Y F; Cao, T (Acta Pharm Sinic, 2016)
et al.